XML 82 R50.htm IDEA: XBRL DOCUMENT v3.25.0.1
Discontinued Operations (Tables)
 12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations
A summary of the carrying amounts of major assets and liabilities, which were classified as held for settlement in the Consolidated Balance Sheets, follows:
December 31, 2024December 31, 2023
(in thousands)
Assets(1)
Cash and cash equivalents$— $6,456 
Surety bond and deposits— 55,089 
Non-Insurance receivable— 10,926 
Total assets$— $72,471 
Liabilities(1)
Unpaid claims$— $2,856 
Accrued salaries and benefits— 110 
Non-Insurance performance year obligation, current— 15,568 
Non-Insurance payable— 41,565 
Total liabilities$— $60,099 
(1) The assets and liabilities of the disposal group are classified as current in the Consolidated Balance Sheet at December 31, 2023.
A summary of the results from discontinued operations included in the Consolidated Statements of Operations and Comprehensive Loss follows:
Year ended December 31,
202420232022
(in thousands)
Revenues:
Non-Insurance revenue$(396)$773,177 $2,380,135 
Total revenues(396)773,177 2,380,135 
Operating Expenses:
Net medical claims incurred(5,276)771,798 2,460,879 
General and administrative expenses1,326 4,482 4,239 
Restructuring costs297 110 — 
Total operating expenses(3,653)776,390 2,465,118 
Gain (loss) from operations3,257 (3,213)(84,983)
Net income (loss)$3,257 $(3,213)$(84,983)
A summary of cash flows from discontinued operations included in the Consolidated Statements of Cash Flows follows:
Year ended December 31,
202420232022
(in thousands)
Net cash (used in) provided by operating activities$(47,605)$(109,514)$100,674 
Schedule of Performance Guarantees
The tables below include the financial statement impacts of the performance guarantee:
December 31, 2024December 31, 2023
(in thousands)
Non-Insurance performance year obligation (1)
$— $15,568 
(1) This obligation represents the consideration due to providers, net of the shared savings or loss for the period and amortization of the liability.
Year ended December 31,
202420232022
(in thousands)
Amortization of the Non-Insurance performance year receivable$— $(751,362)$(2,385,116)
Amortization of the Non-Insurance performance year obligation— 751,362 2,385,116 
Non-Insurance revenue(396)773,177 2,380,135 
Schedule of Reinsurance
The effects of the ACO reinsurance arrangements on the accompanying consolidated financial statements for the years ended December 31, 2024 and 2023, respectively, were as follows:
Year ended December 31,
202420232022
(in thousands)
Non-Insurance revenue, gross and net
$(396)$773,177 2,380,135 
Claims incurred, gross and net(5,276)771,798 2,460,879 
Reinsurance recoverable, gross and net— 10,926 $52,955